Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Takeo Minaguchi

8PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Mar 09, 2026
Impact of prior olaparib use on subsequent platinum-based therapy in recurrent ovarian cancer.

Kaori Ono, Yusuke Kobayashi, Ayumi Shikama

|Jan 09, 2026
Utility of iRECIST for evaluating treatment efficacy in patients receiving immune checkpoint inhibitors.

Genta Irie, Yusuke Kobayashi, Ayumi Shikama

|May 26, 2023
Preoperative Venous Thromboembolism Screening and Postoperative Selective Anticoagulant Therapy Effectively Prevents Postoperative Symptomatic Venous Thromboembolism in Gynecological Malignancies: A 15-Year, Single-Center Study.

Nobutaka Tasaka, Takeo Minaguchi, Narushi Iwata

|Apr 30, 2022
Differential roles of the Wip1-p38-p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas.

Chenyang Xu, Takeo Minaguchi, Nan Qi

|Mar 10, 2020
Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer.

Nobutaka Tasaka, Takeo Minaguchi, Yoshihiko Hosokawa

|Feb 19, 2020
PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas.

Shuang Zhang, Takeo Minaguchi, Chenyang Xu

Pageof 2

Frequent Collaborators

3 joint publications

Toyomi Satoh

2 joint publications

Takuya Kuboya

2 joint publications

Sari Nakao

2 joint publications

Kaori Takeuchi

2 joint publications

Mizuki Isayama

2 joint publications

Genta Irie

2 joint publications

Yusuke Kobayashi

2 joint publications

Ayumi Shikama

2 joint publications

Mayu Yoshino

2 joint publications

Ayaka Tsuihiji

Frequent Collaborators

3 joint publications

Toyomi Satoh

2 joint publications

Takuya Kuboya

2 joint publications

Sari Nakao

2 joint publications

Kaori Takeuchi

Top Related Videos

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Published on : Feb 24, 2023

2.3K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells

Published on : Feb 08, 2018

15.4K
Venous Thrombosis Assay in a Mouse Model of Cancer
04:40

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on : Jan 05, 2024

2.5K
See more related videos

Top Related Videos

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Published on : Feb 24, 2023

2.3K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells

Published on : Feb 08, 2018

15.4K
Venous Thrombosis Assay in a Mouse Model of Cancer
04:40

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on : Jan 05, 2024

2.5K
See more related videos